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Abstract
CD4
+Foxp3
+ T regulatory cells (Tregs) display phenotypic and functional plasticity that is regulated by cytokines and other
immune cells. Previously, we determined that during co-culture with CD4
+CD25
2 T cells and antigen presenting cells, Tregs
produced IL-17. Here, we investigated the mechanisms underlying the differentiation of IL-17-producing Treg (Tr17) cells
and their molecular and functional properties. We determined that during stimulation via TCR/CD3 and CD28, the
combination of IL-1b and IL-2 was necessary and sufficient for the generation of Tr17 cells. Tr17 cells expressed Runx1
transcription factor, which was required for sustained expression of Foxp3 and RORct and for production of IL-17.
Surprisingly, Tr17 cells also expressed Runx3, which regulated transcription of perforin and granzyme B thereby mediating
cytotoxic activity. Our studies indicate that Tr17 cells concomitantly express Foxp3, RORct, Runx1 and Runx3 and are
capable of producing IL-17 while mediating potent suppressive and cytotoxic function.
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Introduction
Tight regulation of effector T cell responses is required for
effective control of infections and avoidance of autoimmunity.
Tregs have essential roles in the maintenance of immune
homeostasis. During the past few years a series of studies have
shown that subsets of Tregs have the propensity to differentiate
into Th17 or Tfh cells [1,2,3,4]. By genetic fate mapping using
Foxp3-Cre mice to mark cells that expressed Foxp3 at some stage
of development, at least one quarter of small intestinal IL-17
producing cells were found to express Foxp3 during their ontogeny
[5]. It has been proposed that this might be the outcome of
stochastic activation of Foxp3 expression or, alternatively, the co-
expression of Foxp3 and IL-17 might mark a distinct differenti-
ation pathway [6]. IL-17
+Foxp3
+ T cells not only have been
observed under experimental conditions but have been identified
in the inflamed intestinal mucosa of patients with Crohn’s disease
and are associated colon cancer in the context of ulcerative colitis
[7,8]. These findings strongly suggest that differentiation of IL-17
+
Tregs is a natural process that can occur under physiologic or
immunopathologic conditions in vivo.
Foxp3 plays a negative role in IL-17 expression through
physical interaction with Runx1 and RORct, thereby inhibiting
their transactivation activity [5,9]. Runx1 is highly expressed in
CD4
+ T lymphocytes [10] as well as Foxp3
+ Tregs and interaction
between Runx1 and Foxp3 is essential for the function of Foxp3
[11]. Runx1 also has a significant role in Th17 differentiation due
to its ability to induce expression of RORct and to associate with
and to act together with RORct to induce Il17 transcription [12].
Runx3 also regulates expression of Foxp3 [13,14]. However, in
contrast to Runx1 that is expressed on CD4
+ T cells, Runx3 is
predominantly expressed in CD8
+ T cells, and cooperates with T-
box proteins to establish the transcriptional program of effector
cytotoxic T lymphocytes [15].
We have previously determined that during co-culture with
CD4
+CD25
2 T cells in the presence of antigen presenting cells
(APC), a fraction of Tregs differentiated into IL-17-producing,
Tr17 cells [16]. In the present study we examined the mechanisms
underlying the differentiation of Tr17 cells and their molecular
and functional properties.
Results
Tr17 cells retain phenotypic properties of Tregs
We have previously reported that during co-culture of
CD4
+CD25
2 cells and Tregs in the presence of APC, IL-1b
and IL-2, endogenous products of the co-culture, were essential for
the generation of Tr17 cells [16]. To determine whether these
cytokines were necessary and sufficient to induce differentiation of
Tr17 cells, we used Foxp3.GFP knock-in mice to isolate highly
purified Tregs. CD4
+Foxp3
+ Tregs were cultured in an APC-free
system using anti-CD3/CD28 mAbs in the presence of IL-1b, IL-
2 or their combination. A significant amount of IL-17 secretion
was observed only when a combination of IL-1b and IL-2 was
added (thereafter termed polarizing culture conditions) (Fig. 1A).
Intracellular staining confirmed the generation of IL-17 producing
PLOS ONE | www.plosone.org 1 September 2012 | Volume 7 | Issue 9 | e45115Tregs (Fig. 1B). Because IL-17 secretion is associated with
expression of RORct [17], we assessed the expression of RORct.
Activation of Tregs under polarizing conditions resulted in
upregulation of RORct, while expression of Foxp3 was retained
(Fig. 1C). Tr17 cells expressed significantly higher levels of RORct
compared to Tregs that remained IL-17
2 during polarizing
culture (Fig. 1D and Fig. S1), consistent with previous reports on
IL-17
+Foxp3
+ T cells identified in different systems [18,19]. Thus
although the expression of Foxp3 remained unchanged, the level
of RORct expression in Tregs positively correlated with their
ability to produce IL-17.
To determine whether Tr17 cells retained phenotypic proper-
ties of Tregs we examined well-established markers. Expression of
CTLA-4 and GITR was comparable between Tr17 and IL-17
2
Tregs (Fig. 1D). We also examined expression of ICOS that has
been suggested to define distinct subsets of Tregs [20]. Interest-
ingly, Tr17 cells displayed increased ICOS levels as compared to
IL-17
2 Tregs (Fig. 1D), suggesting that ICOS expression might
identify Tregs that are capable of producing IL-17. Tr17 cells also
expressed Helios (Fig. S2), a marker previously proposed to
identify subsets of Treg cells [21,22].
Expression of Runx1 is required for the differentiation of
Tr17 cells
Our results showed that Tr17 cells expressed enhanced levels of
RORct while retaining expression of Foxp3. To understand the
mechanism underlying this unique property of Tr17 cells, we
focused on Runx1, a transcription factor that can regulate the
expression of both Rorc and Foxp3. Expression of Runx1 in bulk
Tregs was downregulated after culture with anti-CD3/CD28
mAbs (Fig. S3), similarly to previous observations in naı ¨ve CD4
+ T
cells [10]. Expression of Runx1 was also downregulated in bulk
Treg polarizing cultures but to a lower extend (Fig. 2A and
Sig. S3). Strikingly, after gating on IL-17 producer Tregs we
determined that Tr17 cells did not display Runx1 downregulation
Figure 1. Generation and immunophenotype of Tr17 cells. (A) Tregs isolated from Foxp3.GFP knock in mice were stimulated with anti-CD3/
CD28 mAbs alone or in the presence of IL-1b, IL-2 or their combination. Production of IL-17 was measured by ELISA (eBioscience). Data was
representative of five independent experiments. (B) Tregs were cultured with anti-CD3/CD28 alone or in the presence of IL-1b and IL-2 (polarizing
conditions), and were subsequently stimulated with PMA and ionomycin for additional 4 h, followed by intracellular staining with anti-IL-17 antibody.
Numbers indicate percent IL-17
+ cells (upper box) and IL-17
2 cells (lower box) within total live cells. (C) Expression of RORct and Foxp3 in freshly
isolated Tregs (Unstimulated) and in Tregs cultured under polarizing conditions (Stimulated) was assessed by intracellular staining. (D) Expression of
the indicated transcription factors and surface markers was analyzed on gated IL-17
+ and IL-17
2 Tregs. The data (B–D) were representative of three
independent experiments.
doi:10.1371/journal.pone.0045115.g001
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untreated Tregs. In contrast, Runx1 was downregulated in IL-
17
2 Tregs (Fig. 2B). These results indicate that the increased
Runx1 expression in Tr17 cells accounted for the less prominent
downregulation of Runx1 expression in bulk Treg polarizing
cultures. To determine the role of Runx1 in the generation of
Tr17 cells, we attenuated expression of Runx1. Silencing of Runx1
with small interfering RNA (siRNA) during polarizing culture,
significantly reduced the numbers of IL-17
+ cells (0.423%)
compared to transfection with control ‘scrambled’ siRNA
(1.85%) (Fig. 2C), suggesting that Runx1 plays an important role
in regulating IL-17 production in Tregs. Moreover, expression of
Rorc and Foxp3 mRNA was significantly reduced in cells
transfected with Runx1-specific siRNA (Fig. 2D). Thus, Runx1
plays an essential role in the generation of Tr17 cells by regulating
expression of both Rorc and Foxp3 transcription factors.
Previous studies in Th17 cells have identified the IL-17
promoter and one conserved noncoding (enhancer) sequence,
CNS-5, as the regions required for the optimal transcription of the
Il17 gene [12]. Both these regulatory elements contain sequences
that bind the transcription factors RORct and Runx1. Because
Tr17 cells express Foxp3, which has the capacity to interact with
RORct and Runx1, we examined whether this physical interac-
tion might interfere with the ability of these IL-17 regulatory
transcription factors to bind on the relevant regulatory elements of
the Il17 gene, using chromatin immunoprecipitation (ChIP).
Binding of RORct and Runx1 to the Il17 promoter and enhancer
was detected in Tregs cultured under polarizing conditions
(Fig. 2E, F). However, binding of RORct and Runx1 to these
elements in Tr17 was diminished compared to Th17 cells
(Fig. S4). To determine whether Foxp3 might indeed form
complexes with RORct and/or Runx1 bound on the Il17
promoter and enhancer, we did ChIP using Foxp3-specific
Figure 2. Expression of Runx1 is required for the generation of Tr17 cells. (A) Expression of Runx1 in freshly isolated Tregs (Unstimulated)
and in Tregs cultured under polarizing conditions (Stimulated) was assessed by intracellular staining. (B) After four days of polarizing culture,
expression of Runx1 was analyzed on gated IL-17
+ and IL-17
2 Tregs. (C) Tregs were transfected with Runx1-specific siRNA or control (scrambled)
siRNA and were cultured under polarizing conditions followed by intracellular staining for IL-17. The data are representative of two independent
experiments. (D) In the same cells as in (C), expression of Runx1, Rorc and Foxp3 was examined by real time PCR. Bar graphs show results from one out
of two independent experiments. (E, F) Binding of RORct, Runx1 and Foxp3 to the Il17 promoter (E) and enhancer (F) was assessed by ChIP with
antibodies against RORct, Runx1 and Foxp3 in Tregs cultured under polarizing conditions and restimulated for 4 h with PMA and ionomycin. Results
were normalized to input and are shown as fold increase in signal relative to isotype control IgG used as ChIP negative control. Results from one out
of two experiments are shown.
doi:10.1371/journal.pone.0045115.g002
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enhancer in Tr17 cells (Fig. 2E and F) but not in Th17 cells
(Fig. S4). Because no Foxp3 binding sites are present on the Il17
promoter and enhancer [12], these findings suggest that Foxp3
was detected on these elements due to complex formation with
RORct and/or Runx1 bound on these regions of the Il17 gene.
Tr17 cells display potent suppressive activity
To determine whether Tr17 retained their functional role as
Tregs, we performed suppression assay. Upon culture of
CD4
+CD25
2 responder T cells (Tresp) with anti-CD3/CD28
mAbs,approximately37%ofTrespunderwentatleastoneroundof
cell division (Fig. 3A, first panel). Only 19% of Tresp divided when
they were co-cultured with freshly isolated Tregs (Fig. 3A, second
panel) and 16% of Tregs divided when they were co-cultured with
Treg that were previously stimulated with anti-CD3-plus-anti-
CD28 in vitro (Fig. 3A, third panel). Interestingly, further reduced
proportion of Tresp (11%) proliferated when co-cultured with Treg
that had been previously incubated under polarizing culture
conditions (Fig. 3A, forth panel), suggesting that the inhibitory
capacity of these Tregs was enhanced. In order to analyze more
accurately the suppressive function of Tr17 cells, we used cytokine
capture to isolate highly purified populations of IL-17+ (Tr17) and
IL-172Tregs.SuppressionassayindicatedthatTr17cellsdisplayed
morepotentinhibitoryfunctioncomparedtoIL-172Tregsandthis
effect was dose dependent (Fig. 3B, C). Specifically, at Treg: Tresp
ratio of 1:8, co-culture of Tr17 with Tresp led to only 3% of Tresp
cells undergoing cell division, whereas twice as many Tresp
proliferated when co-cultured with IL-17
2 Tregs. Furthermore, at
Treg:Trespratio of1:1,co-cultureofTr17withTresp ledtoalmost
undetectable response. During this analysis, we noted an increased
percentage of dead cells in the co-cultures of Tresp with Tr17 as
compared to IL-172 Tregs. To distinguish between anti-prolifer-
ative and cytotoxic effects of Tregs, we simultaneously assessed
induction of cell death in CFSE-labeled Tresp co-stained with
DAPI. There was a dose-dependent increase in Tresp cell death
when co-cultured with Tregs and this effect was more prominent
upon co-culture with Tr17 cells (Fig. 3B).
Perforin and granzyme B are highly expressed in Tr17
cells
One of the proposed mechanisms for Treg-mediated suppression
involvescytolysisofTrespcellsviathegranzymeB-perforinpathway
[23,24,25].WeinvestigatedwhetherTr17cellsexpressedgranzyme
BandperforinandutilizedthispathwaytoinducecytolysisofTresp.
Flow cytometry analysis revealed that Tr17 cells expressed higher
levels of perforin and granzyme B compared to IL-17
2 Tregs
(Fig. 4A). To identify the degranulation capacity of Tr17 cells we
assessed CD107a (LAMP-1), a marker of degranulation in CD8
+
and NK cells [26,27]. After polarizing culture, Tregs were co-
cultured with Tresp isolated from B6 congenic mice (Thy1.1
+) and
expression of CD107a was examined. Mean fluorescence intensity
(MFI) of CD107a in Tregs was 4-fold higher than in Tresp cells
(Fig. 4B, bottom, left panel). Furthermore, expression of CD107a in
Tr17 cells was significantly enhanced compared to IL-17
2 Tregs
(Fig. 4B bottom, right panel), indicating that degranulation is a
function preferentially exerted by Tr17 cells.
Runx3 plays a critical role in CTL differentiation and regulates
expression of Gzmb and Prf1 either as a sole factor or in synergy
with other transcription factors [15]. Expression of Runx3 was low
in freshly isolated Tregs and was only slightly upregulated in bulk
Tregs during polarizing culture (Fig. 4C). However, assessment of
Runx3 on Tr17 and IL-17
2 Tregs indicated that Tr17 cells
expressed significantly higher levels of Runx3 protein (Fig. 4C). To
determine whether Runx3 had a causative role in regulating
expression of granzyme B and perforin in Tregs, we used Runx3-
specific siRNA. Runx3 siRNA reduced Runx3 mRNA expression
during polarizing culture by 47% (Fig. 4D). A comparable
reduction was also observed in granzyme B and perforin mRNA
(Fig. 4D) indicating that Runx3 had an active role in regulating
these genes in Tr17 cells.
Discussion
In our present study we determined that similarly to Th17 cells,
in Tr17 cells Runx1 and RORct bind on the previously identified
binding elements of the Il17 gene but the abundance of these
transcription factors on the relevant DNA elements is significantly
lower. Tr17 cells express Foxp3, which plays a negative role in IL-
17 expression because via its physical interaction with RORct and
Runx1 inhibits their transactivation activity [5,12]. Our findings
strongly suggest that the reduced abundance of RORct and
Runx1 on the IL-17 promoter and enhancer of Tr17 cells might
be related to their association with Foxp3, which was also detected
in the same DNA elements by CHIP in Tr17 but not in Th17 cells.
Runx1 and Runx3 transcription factors play key roles in T cell
development and differentiation [28]. Runx1 is highly expressed in
resting CD4
+ T cells but signals mediated by TCR during
activation rapidly downregulate Runx1 via negative autoregula-
tion of the distal Runx1 promoter [10]. Runx1 plays an essential
role in the generation and function of Treg and Th17 cells [11,12].
It was previously shown that Runx1 regulates Il17 transcription in
CD4
+ T cells [12]. However, in that study the expression pattern
of endogenous Runx1 during differentiation of CD4
+ T cells to
Th17 was not investigated. In our studies we examined the
expression pattern of endogenous Runx1 in Tregs during their
differentiation to Tr17. We found that in the presence of IL-1b
and IL-2, expression of Runx1 not only was retained but was even
increased compared to unstimulated Tregs. Furthermore, silencing
Runx1 expression by siRNA reduced the number of Tr17 cells.
Our results strongly suggest that sustained expression of Runx1 in
Tregs is regulated by polarizing cytokines and is required for the
differentiation of Tregs to Tr17 cells.
An additional novel and unexpected finding of our studies was
that Tr17 cells expressed increased levels of perforin and
granzyme B, and displayed enhanced cytotoxic activity compared
to IL-17
2 Tregs. Furthermore, Tr17 cells displayed increased
expression of Runx3, which is involved in the expression of Prf1
and Gzmb genes, thereby regulating cytolytic function. Unlike
Runx1, Runx3 is not expressed in naı ¨ve CD4
+ T cells but is
induced during Th1 differentiation [29]. Runx3 is also expressed
in CD8
+ T cells and regulates transcription of Prf1 and Gzmb
through binding on multiple regulatory regions of both genes,
including their transcription start sites [15]. Runx3 has no effect
on the differentiation of Th17 cells [12]. In contrast to this finding
in Th17 cells, our results showed increased expression of Runx3 in
Tr17 cells, which was functionally important. In CD8
+ T cells,
expression of Runx3 requires the presence of T-bet and is
necessary for the induction of Eomes. In that setting, Runx3
cooperates with T-bet to regulate transcription of granzyme B and
with Eomes to regulate transcription of perforin [15]. Further
studies will determine whether Runx3 is downstream of T-bet and
whether it regulates expression of Eomes in Tr17 cells.
The functional efficacy of Tregs in vivo is programmed by
environmental cues. Such functional adaptation may improve the
ability of Tregs to control different classes of immune responses
driven by distinct types of T effector cells. For example, in
response to interferon-c Tregs express increased levels of Th1-
Tr17 Cells Produce IL-17 and Mediate Cytolysis
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chemokine receptor CXCR3, which enables T-bet
+ Tregs to share
similar migratory properties with Th1 cells and to accumulate at
the same sites thereby controlling Th1-mediated inflammation
[30]. It is intriguing to speculate that Tr17 cells might be
differentiated in an inflammatory microenvironment and might be
programmed to regulate Th17-mediated inflammatory responses.
In conclusion, our studies indicate that Tr17 cells concomitantly
express Foxp3, RORct, Runx1 and Runx3 and are capable of
producing IL-17 while mediating potent suppressive function.
These findings might have significant implications in our
understanding of how environmental cues translate into determi-
nants of Treg fate and might guide the development of therapeutic
strategies that use the administration of Tregs for the treatment of
autoimmune diseases.
Materials and Methods
Ethics Statement
All experiments were conducted in accordance with National
Institutes of Health guidelines. The studies were reviewed and
approved by the Institutional Animal Care and Use Committee
(Approved Protocol Number: #122-2010).
Mice
Foxp3-GFP knock-in (C57BL/6 background) from Dr. Mo-
hamed Oukka (Brigham and Women’s Hospital, Boston, MA),
C57/B6 (Charles River, MA) and B6.PL (The Jackson Labora-
tory, Bar Harbor, ME) were used.
Cell culture
CD4
+ T cells were isolated using CD4
+ T Cell Isolation Kit
(Miltenyi Biotec) and CD4
+Foxp3.GFP
+ Tregs were sorted by flow
cytometry. Tregs (1610
6 cells/ml) were stimulated with anti-CD3
(1 mg/ml) and anti-CD28 (1 mg/ml) mAbs alone or in the presence
of IL-1b (10 ng/ml), IL-2 (10 ng/ml) or both for 4 days. For
differentiation of Th17 cells, CD4
+ T cells (1610
6 cells/ml) were
cultured with anti-CD3/anti-CD28 mAbs in the presence of TGF-
b (2 ng/ml) and IL-6 (20 ng/ml).
Suppression Assay
To assess suppressive activity of IL-17
2 Tregs and Tr17 cells,
after polarizing culture IL-17
+ cells were enriched by cytokine
Figure 3. Tr17 cells display potent suppressive activity. (A) CFSE-labeled CD4
+CD25
2 T cells (Tresp) from PL mice expressing Thy1.1 were
cultured with anti-CD3/CD28 either alone or with indicated Tregs and cell divisions were assessed by CFSE dye dilution. The numbers indicate percent
proliferating cells within total live Thy1.1
+ cells (Tresp). (B) Tregs were cultured under polarizing conditions and IL-17
+ and IL-17
2 cells were sorted by
cytokine capture and flow cytometry. CFSE-labeled Tresp cells from PL mice were cultured with anti-CD3/CD28 either alone or with Tr17 or IL-17
2
Tregs for 4 d. Cell proliferation and death of Thy1.1
+ Tresp cells were simultaneously assessed by co-staining with DAPI. Numbers indicate percent of
dead cells within the Thy1.1
+ population. (C) Proliferation of DAPI
2 Tresp cells was analyzed by flow cytometry. The data (A–C) are representative of
three independent experiments.
doi:10.1371/journal.pone.0045115.g003
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according to the manufacturer’s protocol. Flow cytometry-sorted
IL-17
+GFP
+ and IL-17
2GFP
+ cells were used for suppression
assay using as responder CD4
+CD25
2 cells from B6.PL congenic
mice labeled with CFSE and DAPI. Percent of dividing cells was
calculated using a described formula [31].
Degranulation Assay
Tregs were stimulated with PMA plus ionomycin for 4 h and
were cultured with CD4
+ T cells from B6.PL mice and anti-CD3/
CD28 mAbs in the presence of PE-conjugated antibody against
CD107a (BD Pharmingen, clone 1D4B). Cells were collected,
stained with antibodies against Thy1.1 and IL-17 and analyzed by
flow cytometry.
RNA-mediated interference
For knockdown of Runx1 and Runx3, CD4
+Foxp3.GFP
+ cells
were transfected by nucleofection (Amaxa; X-01 Program) with
siRNA specific for Runx1, Runx3 or ‘scrambled’ control siRNA
(Dharmacon). After 48 h of culture, RNA was extracted and
analyzed by real-time RT-PCR for expression of Runx1, Rorc,
Foxp3, Runx3, Prf1 and Gzmb. Real time PCR primers and probes
were obtained from Applied Biosystems.
ChIP assay
Tregs and CD4
+ T cells were cultured for 4 days under the
indicated conditions and ChIP assay was performed using Pierce
Agarose ChIP kit (Thermo Scientific) according to manufacturer’s
instructions. Antibodies used for IP were specific for Runx1 (Active
Motif), RORct (Santa Cruz Biotechnology), Foxp3 (Santa Cruz
Biotechnology) or IgG isotype control.
Statistical analysis
To assess statistical significance of quantitative differences of
various parameters, t-test was used. Differences were considered
statistically significant for p values ,0.05 (* corresponds to
p,0.05; ** corresponds to p,0.001).
Supporting Information
Figure S1 Characterization of Tr17 cells. Purified
Foxp3.GFP
+CD4
+ T cells were cultured with anti-CD3/CD28
Figure 4. Expression of perforin, granzyme B and Runx3 in Tr17 cells. (A) Tregs were cultured under polarizing conditions and were
restimulated with PMA and ionomycin for 4 h, followed by intracellular staining with antibodies specific for IL-17, perforin and granzyme B and
expression was analyzed in IL-17
+ and IL-17
2 cells. Results are representative of 4 independent experiments. (B) Tregs cultured under polarizing
conditions were harvested and co-cultured with CD4
+CD25
2 Thy1.1
+ Tresp cells and anti-CD3/CD28 in the presence of PE-conjugated antibody
against CD107a for 2 h. The left histograms (upper and lower) show expression of CD107a on Tresp and Treg cells; the right histograms (upper and
lower) show expression of CD107a in IL-17
2 Treg and Tr17 cells. (C) After culture under polarizing conditions, expression of Runx3 in bulk Treg (left
panel) and in gated IL-17
+ or IL-17
2 Treg (right panel) was analyzed by intracellular staining. (D) Tregs transfected with scrambled siRNA or Runx3-
specific siRNA were cultured under polarizing conditions for 48 h and expression of Runx3, Prf1 and Gzmb mRNA was examined by real-time PCR.
Results from one out of two experiments are shown.
doi:10.1371/journal.pone.0045115.g004
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1b and IL-2 (A) for 4 days. Expression of IL-17 (A), RORct( B),
Foxp3 (C) and Runx1 was examined. The results show mean value
and SD of 3–5 independent experiments. (*) indicates p,0.05, and
(**) indicates p,0.001.
(PDF)
Figure S2 Helios is expressed in Tr17 cells. (A) Expression
of Helios in Freshly purified Foxp3.GFP
+ cells was analyzed were
stained with anti-Helios and Foxp3 antibodies followed by flow
cytometry. (B) Foxp3.GFP
+ cells were stimulated with anti-CD3/
CD28 in the presence or absence of IL-1b and IL-2. Four days
after the culture, the cells were stained with antibodies against
Helios and IL-17.
(PDF)
Figure S3 Downregulation of Runx1 expression upon
activation of Treg cells. Treg cells freshly isolated from
Foxp3.GFP knock-in mice, Treg cells cultured in vitro with anti-
CD3/CD28 mAbs and Treg cells cultured in vitro with anti-CD3/
CD28 in the presence of IL-1b and IL-2 for 4 days were examined
for expression of Runx1 by intracellular staining.
(PDF)
Figure S4 RORct and Runx1 but not Foxp3 bind to the
Il17 promoter and enhancer during Th17 differentia-
tion. Binding of endogenous RORct, Runx1 and Foxp3 to the
Il17 promoter and enhancer was assessed by ChIP with antibodies
against RORct, Runx1 and Foxp3 in CD4
+ T cells cultured for
4 d with aCD3/CD28 in the presence of TGF-b and IL-6 (Th17-
polarizing conditions) and restimulated for 4 h with PMA and
ionomycin. Results were normalized to input and are shown as -
fold increase in signal relative to isotype control IgG used as ChIP
negative control. Bar graphs show mean values and SD of
triplicate samples from one out of two experiments.
(PDF)
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